Disease-modifying targets and strategies for Alzheimer's disease and Parkinson's disease

被引：0
|
作者：
Gao, Xiaoya [1 ,2 ]
机构：
[1] Southern Med Univ, Zhujiang Hosp, Dept Pediat Neurol, Guangzhou, Guangdong, Peoples R China
[2] Southern Med Univ, Zhujiang Hosp, Dept Neurol, Guangzhou, Guangdong, Peoples R China
来源：
FRONTIERS IN AGING NEUROSCIENCE | 2023年 / 15卷
关键词：
Alzheimer's disease; Parkinson's disease; disease modification; neuroprotection; novel targets; neurodegeneration;
D O I：
10.3389/fnagi.2023.1247256
中图分类号：
R592 [老年病学]; C [社会科学总论];
学科分类号：
03 ; 0303 ; 100203 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Disease-Modifying Strategies for Parkinson's Disease
    Kalia, Lorraine V.
    Kalia, Suneil K.
    Lang, Anthony E.
    MOVEMENT DISORDERS, 2015, 30 (11) : 1442 - 1450
  • [2] Disease-modifying therapies in Alzheimer's disease
    Salloway, Stephen
    Mintzer, Jacobo
    Weiner, Myron F.
    Cummings, Jeffrey L.
    ALZHEIMERS & DEMENTIA, 2008, 4 (02) : 65 - 79
  • [3] A Chronological Review of Potential Disease-Modifying Therapeutic Strategies for Alzheimer's Disease
    Ettcheto, Miren
    Busquets, Oriol
    Espinosa-Jimenez, Triana
    Verdaguer, Ester
    Auladell, Carme
    Camins, Antoni
    CURRENT PHARMACEUTICAL DESIGN, 2020, 26 (12) : 1286 - 1299
  • [4] Disease-modifying drugs and Parkinson's disease
    Allain, Herve
    Bentue-Ferrer, Daniele
    Akwa, Yvette
    PROGRESS IN NEUROBIOLOGY, 2008, 84 (01) : 25 - 39
  • [5] Defining and labeling disease-modifying treatments for Alzheimer's disease
    Cummings, Jeffrey L.
    ALZHEIMERS & DEMENTIA, 2009, 5 (05) : 406 - 418
  • [6] Novel Disease-Modifying Therapies for Alzheimer's Disease
    Jiang, Teng
    Yu, Jin-Tai
    Tan, Lan
    JOURNAL OF ALZHEIMERS DISEASE, 2012, 31 (03) : 475 - 492
  • [7] Disease-modifying drugs in Alzheimer's disease
    Ghezzi, Laura
    Scarpini, Elio
    Galimberti, Daniela
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2013, 7 : 1471 - 1479
  • [8] A review of clinical trial designs used to detect a disease-modifying effect of drug therapy in Alzheimer's disease and Parkinson's disease
    McGhee, David J. M.
    Ritchie, Craig W.
    Zajicek, John P.
    Counsell, Carl E.
    BMC NEUROLOGY, 2016, 16
  • [9] Challenges to the development of disease-modifying therapies in Parkinson's disease
    Schapira, A. H. V.
    EUROPEAN JOURNAL OF NEUROLOGY, 2011, 18 : 16 - 21
  • [10] Iron neurochemistry in Alzheimer's disease and Parkinson's disease: targets for therapeutics
    Belaidi, Abdel A.
    Bush, Ashley I.
    JOURNAL OF NEUROCHEMISTRY, 2016, 139 : 179 - 197
12345